Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity by Nyffenegger, Christian et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase
activity
Nyffenegger, Christian; Nordvang, Rune Thorbjørn; Jers, Carsten; Meyer, Anne S.; Mikkelsen, Jørn
Dalgaard
Published in:
PLOS ONE
Link to article, DOI:
10.1371/journal.pone.0171585
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Nyffenegger, C., Nordvang, R. T., Jers, C., Meyer, A. S., & Mikkelsen, J. D. (2017). Design of Trypanosoma
rangeli sialidase mutants with improved trans-sialidase activity. PLOS ONE, 12(2), [e0171585]. DOI:
10.1371/journal.pone.0171585
RESEARCH ARTICLE
Design of Trypanosoma rangeli sialidase
mutants with improved trans-sialidase activity
Christian Nyffenegger, Rune Thorbjørn Nordvang, Carsten Jers*, Anne S. Meyer, Jørn
Dalgaard Mikkelsen
Center for BioProcess Engineering, Department of Chemical and Biochemical Engineering, Technical
University of Denmark, Kgs. Lyngby, Denmark
* cjer@dtu.dk
Abstract
A sialidase (EC 3.2.1.18) from the non-pathogenic Trypanosoma rangeli, TrSA, has been
shown to exert trans-sialidase activity after mutation of five specific amino acids in the active
site (M96V, A98P, S120Y, G249Y, Q284P) to form the so-called TrSA5mut enzyme. By
computational and hypothesis driven approaches additional mutations enhancing the trans-
sialidase activity have been suggested. In the present work, we made a systematic combi-
nation of these mutations leading to seven new variants of the T. rangeli sialidase, having
6–16 targeted amino acid mutations. The resulting enzyme variants were analyzed via kinet-
ics for their ability to carry out trans-sialidase reaction using CGMP and D-lactose as sub-
strates. The sialidase variants with 15 and 16 mutations, respectively, exhibited significantly
improved trans-sialidase activity for D-lactose sialylation. Our results corroborate, that
computational studies of trans-glycosylation can be a valuable input in the design of novel
trans-glycosidases, but also highlight the importance of experimental validation in order to
assess the performance. In conclusion, two of the seven mutants displayed a dramatic
switch in specificity from hydrolysis towards trans-sialylation and constitute the most potent
trans-sialidase mutants of TrSA described in literature to date.
Introduction
Human milk oligosaccharides (HMO) are comprised of a backbone of D-lactose elongated
with N-acetyl-D-glucosamine and D-galactose which can be decorated with L-fucose and/or
sialic acid (SA) residues. They are present in human milk in concentrations of 12–14 g/L and
have been attributed a number of beneficial effects including acting as prebiotics, preventing
pathogen adhesion, modulation of immune and cell responses, and supplying nutrients for
brain development [1]. Amongst the subset of sialylated HMOs, 3’-sialyl-D-lactose (3’SL), has
been shown to reduce adhesion and invasion of Escherichia coli in vitro [1–3]. Moreover, 6’-
sialyl-D-lactose was recently shown to reduce food allergy symptoms in mice [4].
While HMOs are abundant in human milk, only trace amounts are present in infant formula
based on bovine milk. Therefore the production of HMOs is receiving increased attention, both
for commercial use as well as for functional studies of individual HMOs. The trans-sialidase
from the human pathogen Trypanosoma cruzi (TcTS) exhibits high trans-sialidase activity and
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low hydrolytic activity and has previously been used for enzymatic glycan sialylation [5]. How-
ever, for industrial production of food-grade HMOs, it is a drawback that the enzyme consti-
tutes an important virulence factor in T. cruzi [6]. Redesigning mutants of the non-pathogenic
T. rangeli sialidase (TrSA), which possesses relatively low trans-sialidase activity, provides an
attractive alternative for application in bioconversion processes. TrSA has 70% sequence iden-
tity to TcTS, has the same overall tertiary structure, and both enzymes have been extensively
characterized by biochemical, mutational and structural studies. TrSA and TcTS are both mem-
bers of the glycoside hydrolase family 33 and share a common double displacement mechanism
with a tyrosine as catalytic nucleophile [7,8]. Despite the high sequence identity between TcTS
and TrSA, it has proven difficult to pinpoint the amino acids necessary for trans-sialidase activ-
ity [9–11]. Paris and co-workers showed that introduction of the five mutations M96V, A98P,
S120Y, G249Y, and Q284P in TrSA (TrSA5mut) is needed to confer detectable trans-sialidase
activity (0.9% compared to TcTS) and either of the mutations I37L or G342A leads to a 12-fold
improvement in trans-sialidase activity [10]. TrSA5mut I37L (TrSA6mut) has been expressed in
Pichia pastoris and was used for synthesis of 3’SL as well as other sialylated glycans [12]. In a
subsequent study, we identified a highly charged loop region (amino acids 197–203) 14 Å from
the acceptor binding site in TcTS [11]. Introducing the seven-amino acid motif in TrSA6mut (to
generate TrSA13mut) reduces the hydrolytic activity without significantly affecting the trans-sia-
lidase activity, thus allowing higher product yields due to reduced sialyl-donor and product de-
sialylation [11].
In a recent study, free-energy profiles for the conversion of the Michaelis complex (MC) into
the covalent intermediate (CI) were computed for TcTS, TrSA and TrSA5mut demonstrating that
the covalent intermediate (CI) in TcTS is less stable than in TrSA [13]. The consequence of higher
stability of the CI is a higher barrier for the reverse reaction, i.e. the step necessary for trans-siali-
dase activity [13]. Using energy decomposition analysis, the contribution to CI stability of individ-
ual active site residues in TrSA5mut was calculated. The five most CI stabilizing residues include
three of the five mutated residues (D97, W313, and E358) indicating slightly different positioning
as well as two residues not identical with the respective residues in TcTS (F59 and D285, which
correspond to N58 and G284 in TcTS). T39A was predicted to change the stability of the CI indi-
rectly by modifying the conformation of E358 [13]. The mutations I37L and G342A, also identi-
fied by Paris and co-workers [10], were proposed to increase the participation of the nucleophile
at the transition state by improving the mobility of the nucleophile [13]. Collectively, they pro-
posed that introducing the mutations I37L, T39A, F59N, D285G and G342A in TrSA5mut would
yield an enzyme with high trans-sialidase activity. This, however, was not confirmed experiment-
ally.
Development of trans-glycosidases from natural hydrolases aims at increasing the ratio of
trans-glycosidase vs hydrolase activity. In general, both donor and product can be subject to
the hydrolytic activity, which leads to reduced product yields as well as contamination with
monosaccharides (in case of exo-glycosidases). It is thus paramount to eliminate or reduce
the hydrolytic activity. Reaction condition design, and especially the use of high substrate con-
centrations, has been shown to favour trans-glycosylation activity over hydrolase activity for
trans-sialidases and other trans-glycosidases in e.g. galactooligosaccharide production [12,14].
Insights from trans-glycosidase engineering indicate that mutations in the donor sugar binding
site compared to mutation in the acceptor binding site in general are more likely to decrease
hydrolytic activity [15].
In this paper, the findings of the three studies conducted by Paris et al., Jers et al., and Pier-
dominici-Sottile et al. [10,11,13] were integrated in an effort to design a sialidase derived from
T. rangeli with improved trans-sialidase activity and/or reduced hydrolytic activity. Among the
mutations analyzed in this study, the structural mutation I37L, the energetic mutations T39A,
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and D286G are located in the donor binding site, whereas the energetic mutation Y58N is the
only mutation in the acceptor binding site. The loop mutations are located further away but
were hypothesized to affect the water network in the active site [11]. In the present work, the
mutations were split into three groups and systematic combination of these resulted in a total
of seven mutants which were constructed, expressed, and tested experimentally. This led to
identification of two novel enzymes with improved trans-sialidase activity and reduced hydro-
lase activity.
Materials and methods
Substrates
3’SL was purchased from Carbosynth (Compton, United Kingdom). The commercial casein
glycomacropeptide (CGMP) product Lacprodan1 CGMP-20 containing 5.7% (w/w) cova-
lently linked sialic acid was a gift from Arla Foods amba (Viby, Denmark). Before use, low
molecular weight impurities in the CGMP solution were removed by filtration using a 5 kDa
membrane (Sartorius AG, Goettingen, Germany) as a technical precaution relating to High-
performance anion exchange chromatography (HPAEC) analysis. All other chemicals were
purchased from Sigma-Aldrich (Steinheim, Germany).
DNA manipulations and strain construction
Construction of His6-tagged genes encoding TrSA6mut and TrSA13mut for secreted expression
in P. pastoris was described previously [12,11]. These genes were used as templates for intro-
duction of additional mutations using the QuikChange II Site-Directed Mutagenesis Kit (Agi-
lent, CA, USA) and mutagenic primers (Table 1). All plasmids were sequenced to confirm the
mutations and the integrity of the genes. Plasmids encoding the different enzyme variants
were propagated in Escherichia coli DH5α, cultured at 37˚C while shaking in low salt LB
medium (10 g/L tryptone, 5 g/L yeast extract and 5 g/L NaCl), supplemented with 25 μg/mL
zeocin. P. pastoris X-33 was transformed with the MssI-linearized vectors by electroporation
following the manufacturer’s instructions (Invitrogen, CA, USA).
Enzyme production and purification
Protein synthesis was performed by cultivation of P. pastoris X-33 harboring pPICZαC with
the mutated genes in shake flasks for three days in accordance with the EasySelect™ Pichia
Table 1. List of primers used for mutagenesis. Mutagenic codons are indicated in bold.
Name Sequence
T39A(I37L)_fwd GGTTCATTCATTTAGATTACCAGCTATCGTTAACGTAGATGGAGT
T39A(I37L)_rev ACTCCATCTACGTTAACGATAGCTGGTAATCTAAATGAATGAACC
F59N_fwd CTGATGCCAGATATGAGACATCAAACGACAACTCCTTTATCGAA
F59N_rev TTCGATAAAGGAGTTGTCGTTTGATGTCTCATATCTGGCATCAG
D285G_fwd CAACTTCCAATCAACCCGGTTGTCAGAGTTCATTCGT
D285G_rev ACGAATGAACTCTGACAACCGGGTTGATTGGAAGTTG
G342A_fwd ATTGGTGATGAAAACAGTGCTTACTCTTCCGTCCTATAC
G342A_rev GTATAGGACGGAAGAGTAAGCACTGTTTTCATCACCAAT
L37I_fwd CGTGTGGTTCATTCATTTAGAATACCAACTATCGTTAACGTAG
L37I_rev CTACGTTAACGATAGTTGGTATTCTAAATGAATGAACCACACG
T39A(I37)_fwd CGTGTGGTTCATTCATTTAGAATACCAGCTATCGTTAACGTAGATGG
T39A(I37)_rev CCATCTACGTTAACGATAGCTGGTATTCTAAATGAATGAACCACACG
doi:10.1371/journal.pone.0171585.t001
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Expression Kit (Invitrogen) protocol. Briefly, induction was carried out in 200 or 1000 mL
BMMY (0.5% methanol) while shaking at 28˚C. Protein synthesis was induced every 24 hours
by addition of methanol to a final concentration of 0.5%. His6-tagged enzymes were purified
as described previously [16]. Protein concentration was estimated by measurement of absor-
bance at 280 nm using extinction coefficients calculated using ProtParam [17].
Trans-sialidase activity analysis
The donor substrate CGMP was purified as described previously [18] with the modification
that all reaction mixtures were prepared in 20 mM phosphate-citrate buffer (pH 6.4). D-Lac-
tose was added to the CGMP solution, to final D-lactose and CGMP concentrations of 7.5 g/L
and 50.6 g/L, respectively. Enzyme preparations were pre-diluted to 57 or 5.7 μg/mL total pro-
tein with 20 mM phosphate-citrate buffer (pH 6.4). Reactions were started by addition of
185 μL pre-diluted enzyme solution to 515 μL substrate mix (both preheated at 30˚C) and the
resulting reaction mixtures, either 1.5 μg/mL (TrSA5mut, TrSA8mut, TrSA12mut, and TrSA15mut)
or 15 μg/mL (TrSA6mut, TrSA9mut, TrSA13mut, and TrSA16mut) enzyme, 16 mM D-lactose, 37
g/L CGMP (corresponding to approximately 4 mM 3’-bound and 4 mM 6’-bound SA [19]),
were incubated at 30˚C with shaking (700 rpm). Note that Trypanosomal trans-sialidases are
generally considered specific for α2,3-bound sialic acid and we have previously shown that
TrSA13mut does not act on 6’-sialyllactose [11] thus making it unlikely that 6’-bound SA would
constitute a substrate. Reactions were terminated by heat inactivation at 90˚C for 10 min and
filtered through a 5 kDa Vivaspin filter (Sartorius) by centrifugation for 10 min at 5000 g and
4˚C. Filtrates were analyzed by HPAEC-PAD as described below. As a control, reactions were
performed using the same enzyme preparations after heat-inactivation at 90˚C for 10 min. All
reactions were done in duplicates. To estimate initial rates, the data points from 5 to 40 min in
each replicate were fitted with a second degree polynomial function and the slopes at time 0
min were calculated.
High-Performance Anion Exchange Chromatography (HPAEC-PAD)
Separation and quantification of reaction products (3’SL and SA) from biocatalytic reactions
were carried out using a Dionex BioLC system consisting of a GS50 gradient pump, an ED50
electrochemical detector and an AS50 chromatography compartment coupled to an AS50
autosampler (Dionex Corp., Sunnyvale, CA) as described previously [18].
Enzyme 3D models
Enzyme 3D models of TrSA mutants were generated using the software PyMol v1.3 (Schro¨-
dinger) by introduction of point mutations in a TrSA crystal structure (PDB 1N1T) [20]. A
TcTS crystal structure (PDB 1S0I) [7] was used as alignment reference.
Results and discussion
Design of TrSA mutants
By combining the findings of previous experimental [10,11] and computational studies [13]
we aimed to design mutants of TrSA with improved trans-sialidase activity and/or reduced
hydrolytic activity. As a starting point, the mutant TrSA5mut was chosen as it was previously
shown to contain the minimal amount of residues necessary for conferring detectable trans-
sialidase activity to the enzyme [10]. Next, we grouped the mutations based on expected func-
tionality, thereby obtaining three groups of mutations that were combined in the TrSA5mut
backbone. The first group was termed “energetic mutations”, and consisted of T39A, F59N,
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and D285G, that based on energy decomposition analysis were predicted to lower the stability
of the CI thus promoting trans-sialidase activity [13]. The second group was termed “structural
mutations” and consisted of I37L and G342A that were predicted to improve the mobility of
the nucleophile [13]. However, due to the fact that eight enzyme variants with the G342A
mutation were expressed at levels insufficient for enzyme activity measurements, the group
was subsequently reduced to only include I37L. The third group was termed “loop mutation”
and consisted of the highly positively charged seven amino acid motif (VTNKKKQ) that,
when introduced in TrSA6mut, led to a reduced hydrolase activity without negatively affecting
the trans-sialidase activity [11]. Introduction of the different combinations of mutation groups
into TrSA5mut led to the design of seven mutant enzymes containing 1 to 11 additional point
mutations as summarized in Fig 1.
Enzyme production in P. pastoris
To test the designed enzymes, we constructed genes encoding the enzyme variants and expressed
them in the yeast P. pastoris. Expression levels of successfully expressed mutant variants were in
the range of 100–850 μg/L, which was sufficient for the analyses performed in this study. As
mentioned in the previous section, extremely low or no expression was observed for eight vari-
ants carrying the mutation G342A alone or in combination with I37L, respectively. This was also
observed previously when expressed in E. coli [10]. In contrast, we observed that variants with
only the I37L mutation expressed well in P. pastoris [12]. In order to find an explanation for the
unsuccessful expression of variants carrying the G342A mutation, we compared the crystal struc-
tures of TrSA [20] and TcTS [7], and observed a significant structural difference between the
two enzymes that could potentially explain the observed low production (S1 Fig).
Trans-sialidase activity assessment
To evaluate the novel TrSA mutant enzymes, we used the commercially interesting sialyl-
donor substrate CGMP in combination with D-lactose as acceptor. As expected for bimolecu-
lar reactions, we previously demonstrated that the use of higher acceptor concentrations
improves trans-sialidase activity, even for enzymes with relatively high hydrolase activity [12].
In order to highlight differences in trans-sialidase activity between the enzyme variants
assessed in this paper, D-lactose was used at a lower concentration (with a donor:acceptor ratio
of 1:4) in time course experiments (Fig 2). We initially optimized the enzyme concentration
based on the activity of TrSA6mut. However, for the four variants without the structural mutation
I37L (TrSA5mut, TrSA8mut TrSA12mut and TrSA15mut; Fig 1) the activity was too high to observe
the initial 3’SL formation rate. Therefore reactions for variants with I37 were done with a 10-fold
lower enzyme concentration compared with those variants carrying the I37L mutation. Overall,
it was observed that all of the mutants produced more 3’SL than the parent enzyme TrSA5mut.
For most variants, only slight improvements in 3’SL formation were observed, whereas TrSA15mut
and TrSA16mut showed dramatic increases in trans-sialidase activity (Fig 2).
The Trypanosomal trans-sialidases and mutants of the T. rangeli sialidase have previously
been reported to be specific for α2,3-sialylation of the terminal sugar [11,12]. From the
HPAEC-PAD analysis it was also evident that 3’SL was the dominant sialylation product for all
enzyme variants (S2 Fig). A minor sialylation product, tentatively 3-sialyllactose (3SL) [21],
was seen for all enzyme variants. TrSA16mut reactions contained only trace amounts of this
compound.
Improved yield of trans-sialylation product can be a consequence of improved trans-sialidase
activity and/or reduced hydrolase activity. To investigate this, we estimated the initial rates of sialic
acid release and 3’SL synthesis from the time course experiments (Table 2). From the specific initial
Design of sialidase mutants with improved trans-sialidase activity
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rates, it is evident that the enzyme variants with the structural mutation I37L, all exhibit a lower
overall activity, while it only in certain contexts appear to substantially improve the trans-sialidase/
hydrolase ratio. When considering the three groups of mutations (structural, energetic, and loop
mutations) individually, it was observed that the loop mutation led to a 2.3-fold higher 3’SL:SA
ratio compared to TrSA5mut, whereas the structural and energetic mutations improved the ratio
Fig 1. Mutations introduced in TrSA. The top panel displays a close-up of the active site with 3’SL docked (yellow, sticks). The 16 mutations introduced in
TrSA16mut are colored according to the various mutation groups: structural mutation (orange), energetic mutations (magenta), loop mutations (cyan) and
mutations part of TrSA5mut (green). The bottom panel offers an overview of the mutation groups and the specific mutations introduced in the different TrSA
mutant enzymes.
doi:10.1371/journal.pone.0171585.g001
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4.4- and 6.8-fold, respectively. As was evident from the time course experiment, the most proficient
enzymes where obtained by combining the loop and energetic mutations (with and without the
structural mutation), TrSA15mut, and TrSA16mut, which led to a 13-fold improvement of the 3’SL:
SA ratio.
Evaluation of time course experiments
TrSA5mut, TrSA6mut and TrSA13mut have all been characterized previously, but this is the first
study in which these mutants have been compared using the same experimental conditions
and kinetic modelling. TrSA6mut was first described as a mutant with a 12-fold improved
trans-sialidase activity compared to the TrSA5mut [10]. The enzymes were assayed at one time
point analyzing product concentrations in the μM range using 3’SL as donor and C14-labeled
D-lactose as acceptor [10]. In trans-glycosylation reactions characterized by an initial product
build-up followed by product degradation, we find that the time course experiment is more
robust to changes in enzyme concentration and sampling time. Using our setup with CGMP
as donor substrate, we observed that the product to hydrolysis ratio was greatly enhanced for
TrSA6mut and this led to an about 7-fold higher maximal product concentration (Fig 2) which
largely support the conclusion of Paris and co-workers [10]. In our previous work, TrSA6mut
and TrSA13mut were compared based on a fluorometric time course assay using an artificial
acceptor substrate [11]. In the study presented here, using a more relevant acceptor substrate
(D-lactose), we confirmed that TrSA13mut performs better than TrSA6mut which was mediated
via both a reduction in trans-sialidase activity but also a substantially higher reduction in
hydrolytic activity of TrSA13mut when compared to the TrSA6mut.
The study of Pierdominici-Sotille and co-workers suggested five mutations to be intro-
duced in TrSA5mut that should yield an enzyme with high trans-sialidase activity comparable
to that of the TcTS [13]. This was not confirmed experimentally in their publication, and in
our hands, production of TrSA10mut was not possible due to the destabilizing mutation
G342A. The closest related, expressed enzyme TrSA9mut (lacking G342A) showed slightly
Fig 2. Time course experiments for 3’SL production. Time course experiments using the different TrSA mutants: TrSA5mut, TrSA6mut, TrSA8mut,
TrSA9mut, TrSA12mut, TrSA13mut, TrSA15mut, and TrSA16mut. The concentration of SA (diamonds) and 3’SL (triangles) at the respective sampling
times is shown. Mutants with the structural mutation (TrSA6mut, TrSA9mut, TrSA13mut, and TrSA16mut) were assayed using 15 μg/mL enzyme and
those without (TrSA5mut, TrSA8mut, TrSA12mut, and TrSA15mut) were assayed using 1.5 μg/mL. TrSA5mut, TrSA6mut and TrSA12mut had a very fast
initial hydrolysis (SA), whereas reasonable amounts of 3’SL were generated by the remaining enzymes. TrSA15mut and TrSA16mut, however
exhibited the highest ratio of 3’SL:SA.
doi:10.1371/journal.pone.0171585.g002
Table 2. Estimated specific initial rates for 3’SL formation and SA release.
Enzyme Trans-sialidase activity Hydrolase activity 3’SL:SA ratio Fold change1
[pmol 3’SL/(min*μg protein)] [pmol SA/(min*μg protein)]
TrSA5mut 5.87±0.24 17.74±0.15 0.33 1
TrSA6mut 2.29±0.03 1.58±0.00 1.45 4.4
TrSA8mut 6.18±0.46 2.77±0.17 2.23 6.8
TrSA9mut 1.69±0.14 0.81±0.08 2.09 6.3
TrSA12mut 7.47±0.93 9.89±0.69 0.76 2.3
TrSA13mut 1.28±0.02 0.51±0.01 2.53 7.7
TrSA15mut 8.56±1.41 1.87±0.07 4.57 13.8
TrSA16mut 1.41±0.09 0.31±0.01 4.48 13.6
1 Fold-change of the 3’SL:SA ratio compared to TrSA5mut
doi:10.1371/journal.pone.0171585.t002
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higher 3’SL production compared to TrSA6mut and this appeared to be mainly due to reduced
hydrolysis activity in TrSA9mut. This could indicate, that although the bioinformatics approach
was able to identify amino acid mutations relevant to the trans-sialidase reaction, it overesti-
mated the impact of these mutations.
With respect to 3’SL production, the variant TrSA16mut containing all three groups of muta-
tions and TrSA15mut without the I37L mutation displayed a substantially higher maximal 3’-SL
production than TrSA13mut and variants with fewer mutations. Both enzymes exhibited a simi-
lar trans-sialidase to hydrolase ratio but whereas TrSA15mut had a slightly increased trans-siali-
dase activity, it was reduced 4-fold in TrSA16mut.
Molecular interpretation of mutations
The structural mutations. The structural mutation I37L greatly reduced the activity for
both the production of 3’SL and free sialic acid, irrespective of the background. It appears
unlikely that the lower activity is solely due to an increased flexibility of the nucleophile. The
reduced activity of the mutants could arise from a rearranged nucleophile, which results in a
covalent intermediate less susceptible to an attack from both water and acceptor, e.g. (i) due to
steric shielding (although Ile and Leu are isomers) or (ii) due to a less optimal interaction of
substrates and the catalytic residues due to a conformation change in the presence of Leu com-
pared to Ile.
The energetic mutations. The energetic mutations when introduced in TrSA5mut did not
affect the trans-sialidase activity but also reduced the hydrolysis activity by a factor of 6.4, thus
making TrSA8mut better at producing 3’SL than TrSA5mut. When introduced into other TrSA-
variants, the energetic mutations generally had limited effect on trans-sialidase activity, led to
more modest decreases in the hydrolytic activity. The higher trans-sialidase activity could be
explained by the proposed destabilization of the covalent intermediate [13], whereas the
decreased product hydrolysis could be (i) due to changes in the water accessibility or (ii) an
alteration of the conformation in the substrate/product bound state, which disfavours hydroly-
sis by e.g. a better indirect exclusion of water from the active site.
The loop mutation. Introduction of the loop mutations generally had little effect on the
trans-sialidase activity, but rather led to a reduction in hydrolysis when compared with the
respective variants without the loop. The loop mutation has been suggested previously to influ-
ence the water network surrounding the active site, thereby hindering water from attacking
the covalent intermediate [11]. This is in good agreement with the lower hydrolase activity
observed when combining the loop mutations with either structural or energetic mutations.
When combined with both of the mutation groups, it appeared however to have a negative
effect on overall activity reducing hydrolase activity more dramatically, but also decreasing the
trans-sialidase activity.
Conclusions
This study combined the results of three previous mutagenesis and bioinformatics studies on
TrSA with the aim of designing enzymes with improved trans-sialidase activity and/or reduced
hydrolytic activity. Three groups of mutations, based on suggested mechanistic properties,
were combined systematically to design seven TrSA mutant variants. The seven variants were
tested in time course experiments to evaluate the effects of the individual mutation groups. All
seven expressed mutants exhibited enhanced trans-sialidase to hydrolase activity ratios com-
pared to the parent enzyme TrSA5mut. Based on the time course experiments, two enzymes,
TrSA15mut and TrSA16mut, stood out as drastically improved with respect to 3’SL production.
These two enzymes exhibited different kinetics due to the I37L mutation in TrSA16mut, which
Design of sialidase mutants with improved trans-sialidase activity
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led to reduced overall activity compared to TrSA15mut. In conclusion, the two enzyme variants,
TrSA15mut and TrSA16mut, constitute further improvements in the development of trans-siali-
dases based on the TrSA5mut, TrSA6mut and TrSA13mut sialidase and should prove useful for
the preparation of sialylated biomolecules.
Supporting information
S1 Fig. Inspection of 3D structures of TrSA and TcTS around TrSA G342. Mutation of
G342 in TrSA led to low/no expression. The figure shows the conformation of the carboxylic
oxygens of TcTS S340 and TrSA S341 adjacent to G341/342 in each of the two enzymes TcTS
and TrSA. (Left) In TcTS the residue assumes a conformation with a disallowed phi/psi angle
set and we suggest that the mutation of the adjacent residue (G341A) might lead to a similar
phi/psi angle set of the S340 in the TrSA since no other differences can be observed in the
structures around S340/S341 (Right). The fact that the disallowed conformation of S340 in
TcTS can exist might be due to an array of stabilizing mutations introduced by evolution. Such
higher stability could explain why TcTS is able to cope with the destabilization caused by S340.
In contrast, our mutagenesis approach would not introduce such compensatory mutations
that would enable the presence of the disallowed conformation.
(TIF)
S2 Fig. HPAEC-PAD chromatograms of trans-sialylation products. Chromatograms from
the analysis of samples at the time of transient maximal 3’SL yield for the enzyme variants
TrSA5mut (25 min), TrSA6mut (40 min), TrSA8mut (120 min), TrSA9mut (40 min), TrSA12mut
(60 min), TrSA13mut (60 min), TrSA15mut (120 min), and TrSA16mut (60 min). The hydrolysis
product SA and the trans-sialidase products 3’SL and the minor sialylation compound () are
marked.
(TIF)
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